A phase 3 trial of Sanofi’s eczema prospect amlitelimab has hit its primary and key secondary endpoints. Yet, with the data falling short of analyst expectations, shares in the company opened down 9% ...

You might love a warm bowl of oatmeal for breakfast, but did you know you can use it on your skin, too? Oatmeal baths are a popular home remedy for skin conditions like atopic dermatitis, the most ...

Thirty-year-old Saanya Ali has lived with eczema for as long as she can remember, but a recent flare-up during a vacation on the Italian coast hit her differently. "It was the worst eczema of my ...

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (delgocitinib) the first therapeutic in the U.S. specifically indicated for chronic hand ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Injections included six for APG777, 11 for ...

Turn Therapeutics today announced the initiation of a randomized, double-blind, vehicle-controlled clinical trial evaluating its topical GX-03 formulation -- previously used in the company's advanced ...

Spongiotic dermatitis is a term that refers to a specific type of skin inflammation. It affects the top layer of the skin (the epidermis), leading to fluid buildup and symptoms such as scaling, ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the ...

A Nektar Therapeutics drug has met the skin clearance goals of a closely watched mid-stage clinical trial in atopic dermatitis. While these preliminary results bring validation to the therapy’s novel ...

Rezpegaldesleukin led to a 53%–61% symptom improvement vs. 31% with placebo after 16 weeks. The stock surged with a volume of 4.7 million, far exceeding the 239.7K average daily volume. Up Next: Get 5 ...